Private Advisor Group LLC Buys 1,603 Shares of Axon Enterprise, Inc (NASDAQ:AXON)

Private Advisor Group LLC grew its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 16.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,258 shares of the biotechnology company's stock after buying an additional 1,603 shares during the period. Private Advisor Group LLC's holdings in Axon Enterprise were worth $5,921,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in AXON. Kentucky Retirement Systems Insurance Trust Fund bought a new position in Axon Enterprise during the 1st quarter valued at about $1,110,000. Quotient Wealth Partners LLC bought a new position in Axon Enterprise in the 1st quarter worth $438,000. CX Institutional bought a new position in shares of Axon Enterprise in the first quarter worth about $115,000. GAMMA Investing LLC raised its stake in Axon Enterprise by 11.8% during the 1st quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company's stock worth $765,000 after acquiring an additional 154 shares during the period. Finally, DAVENPORT & Co LLC raised its position in shares of Axon Enterprise by 5.1% during the 1st quarter. DAVENPORT & Co LLC now owns 940 shares of the biotechnology company's stock valued at $494,000 after purchasing an additional 46 shares during the period. 79.08% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the company an "overweight" rating in a research note on Friday, July 11th. Needham & Company LLC lifted their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. JPMorgan Chase & Co. lifted their price target on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a report on Thursday, July 17th. Wolfe Research assumed coverage on shares of Axon Enterprise in a report on Monday, July 7th. They issued an "outperform" rating on the stock. Finally, Barclays lifted their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday, May 9th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $772.08.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Michael Garnreiter sold 5,913 shares of the business's stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $760.00, for a total transaction of $4,493,880.00. Following the transaction, the director owned 17,740 shares in the company, valued at $13,482,400. The trade was a 25.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, President Joshua Isner sold 9,905 shares of the company's stock in a transaction dated Wednesday, May 21st. The shares were sold at an average price of $738.03, for a total transaction of $7,310,187.15. Following the transaction, the president owned 298,809 shares in the company, valued at $220,530,006.27. The trade was a 3.21% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 34,642 shares of company stock valued at $25,090,528. Insiders own 4.40% of the company's stock.

Axon Enterprise Trading Up 3.9%

NASDAQ AXON traded up $27.78 during trading hours on Friday, hitting $737.04. 164,067 shares of the company were exchanged, compared to its average volume of 699,620. The stock has a 50-day moving average price of $764.16 and a 200 day moving average price of $648.27. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. Axon Enterprise, Inc has a 52 week low of $279.02 and a 52 week high of $830.21. The stock has a market cap of $57.38 billion, a PE ratio of 178.03, a price-to-earnings-growth ratio of 78.61 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.07. The firm had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. The company's revenue for the quarter was up 31.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS. Analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.